NCT03634995View on ClinicalTrials.gov

An Investigational Study to Evaluate the Effects of Experimental Medication BMS-986256 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

August 14, 2018

Primary Completion Date

October 9, 2019

Study Completion Date

October 9, 2019

Conditions
Healthy Participants
Interventions
DRUG

BMS-986256

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Trial Locations (2)

66219

PRA Health Science KK, Lenexa

92801

Anaheim Clinical Trials, Anaheim

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03634995 - An Investigational Study to Evaluate the Effects of Experimental Medication BMS-986256 in Healthy Participants | Biotech Hunter | Biotech Hunter